Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 21, 2024

BUY
$46.37 - $73.65 $185 - $294
4 Added 3.88%
107 $7,000
Q3 2023

Dec 06, 2023

BUY
$52.09 - $64.1 $2,187 - $2,692
42 Added 68.85%
103 $5,000
Q2 2023

Jul 25, 2023

BUY
$54.67 - $66.44 $1,093 - $1,328
20 Added 48.78%
61 $3,000
Q1 2023

May 22, 2023

BUY
$43.8 - $56.99 $394 - $512
9 Added 28.13%
41 $2,000
Q4 2022

Feb 07, 2023

BUY
$44.07 - $54.45 $705 - $871
16 Added 100.0%
32 $1,000
Q3 2022

Nov 09, 2022

BUY
$42.7 - $59.99 $683 - $959
16 New
16 $1,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.